Table 1 Descriptive Result of Categorical Variables of cervical cancer, UoGRH, 2018–2022
Factor | Category | Survival status | Total (%) | |
|---|---|---|---|---|
Censored 204(63.4%) | Event 118(36.6%) | |||
Residence | Rural | 73 (22.7%) | 52(16.1%) | 125(38.8%) |
Urban | 131(40.7%) | 66(20.5%) | 197(61.2%) | |
Educational level | Literate | 126(39.1%) | 63(19.6%) | 189(58.7%) |
Illiterate | 78(24.2%) | 55(17.1%) | 133(41.3%) | |
Co-morbid disease | No | 127(39.4%) | 26(8.1%) | 153(47.5%) |
Yes | 77(23.9%) | 92(28.6%) | 169(52.5%) | |
History of abortion | No | 151(46.9%) | 38(11.8%) | 189(58.7%) |
Yes | 53(16.5%) | 80(24.8%) | 133(41.3%) | |
HIV | No | 163(50.6%) | 21(6.4%) | 184(57%) |
Yes | 41(12.7%) | 97(30.3%) | 138(43%) | |
Stage | early | 106(32.9%) | 25(7.8%) | 131(40.7%) |
Late | 98(30.4%) | 93(28.9%) | 191(59.3%) | |
Oral contraceptive use | No | 93(28.9%) | 18(5.6%) | 111(34.5%) |
Yes | 96(29.8%) | 115(35.7%) | 211(65.5%) | |
Histology type | Adenocarcinoma | 153(47.5%) | 21(6.5%) | 174(54%) |
Squamous cell | 51(15.8%) | 97(30.2%) | 148(46%) | |
LVSI | Yes | 8 (2.5%) | 40 (12.4%) | 48 (14.9%) |
No | 196 (60.9%) | 78 (24.2%) | 274 (85.1%) | |
Chemotherapy | No | 14 (4.3%) | 6 (1.9%) | 20 (6.2%) |
Yes | 190 (59%) | 112 (34.8%) | 302 (93.8%) | |
Grade | Grade 1 | 30 (9.3%) | 22 (6.8%) | 52 (16.1%) |
Grade 2 | 34 (10.6%) | 32 (9.9%) | 66 (20.5%) | |
Grade 3 | 10 (3.1%) | 2 (0.6%) | 12 (3.7%) | |
Grade 4 | 130 (40.4%) | 62 (19.3%) | 192 (59.7%) | |
Radiation | Beam Radiation | 60 (18.6%) | 62 (19.3%) | 122(37.9%) |
Brachytherapy | 36 (11.2%) | 4 (1.2%) | 40(12.4%) | |
BRB | 108 (33.5%) | 52 (16.1%) | 160(49.7%) | |
Regional nodes | Negative | 150(46.58%) | 21(6.5%) | 171(53.11%) |
Positive | 54(16.77%) | 97(30.2%) | 151(46.89%) | |
Metastasis number | 0 | 169 (52.48%) | 108 (33.54%) | 277 (86.02%) |
1 | 17 (5.28%) | 3 (0.93%) | 20 (6.21%) | |
2 | 8 (2.48%) | 3 (0.93%) | 12 (3.73%) | |
 >  = 3 | 10 (3.10%) | 4 (1.24%) | 14 (4.35%) | |
FIGO stage | IA1 | 19 (5.9%) | 2 (0.62%) | 21 (6.52%) |
IA2 | 23 (7.14%) | 3 (0.93%) | 26 (8.07%) | |
IB1 | 17 (5.28%) | 2 (0.62%) | 19 (5.9%) | |
IB2 | 14 (4.35%) | 2 (0.62%) | 16 (4.97%) | |
IIA | 19 (5.9%) | 7 (2.17%) | 26(8.07%) | |
IIB | 14 (4.35%) | 9 (2.79%) | 23 (7.14%) | |
IIIA | 34 (10.56%) | 29 (9%) | 63(19.57%) | |
IIIB | 28 (8.7%) | 30 (9.32%) | 58 (18.01%) | |
IV | 36 (11.2%) | 34 (10.5%) | 70 (21.7%) | |
Tumor size (cm) |  < 4 cm | 170 (52.8%) | 80 (24.8%) | 250 (77.6%) |
 >  = 4 cm | 34 (10.6%) | 38 (11.8%) | 72 (22.4%) | |
Smoking status | No | 186(57.76%) | 52(16.14%) | 238(73.9%) |
Yes | 18(5.6%) | 66(20.5) | 84(26.1%) | |